DE69429569D1 - Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel - Google Patents
Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale MittelInfo
- Publication number
- DE69429569D1 DE69429569D1 DE69429569T DE69429569T DE69429569D1 DE 69429569 D1 DE69429569 D1 DE 69429569D1 DE 69429569 T DE69429569 T DE 69429569T DE 69429569 T DE69429569 T DE 69429569T DE 69429569 D1 DE69429569 D1 DE 69429569D1
- Authority
- DE
- Germany
- Prior art keywords
- cyclopropylmethyl
- hydroxymethyl
- bis
- preparation
- pyrimidine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26349093 | 1993-10-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69429569D1 true DE69429569D1 (de) | 2002-02-07 |
DE69429569T2 DE69429569T2 (de) | 2002-09-19 |
Family
ID=17390246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69429569T Expired - Lifetime DE69429569T2 (de) | 1993-10-21 | 1994-10-21 | Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel |
Country Status (7)
Country | Link |
---|---|
US (1) | US5496824A (de) |
EP (1) | EP0649840B1 (de) |
KR (1) | KR950011530A (de) |
CN (1) | CN1106392A (de) |
CA (1) | CA2134050A1 (de) |
DE (1) | DE69429569T2 (de) |
TW (1) | TW271438B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU710490B2 (en) * | 1996-02-22 | 1999-09-23 | Samjin Pharmaceutical Co., Ltd. | New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
EP3020712B1 (de) | 2011-11-10 | 2018-07-04 | Aratana Therapeutics NV | Verfahren zur herstellung von cyclopropan-derivaten |
US9107943B2 (en) | 2012-01-20 | 2015-08-18 | Aratana Therapeutics Nv | Eye drop composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863927A (en) * | 1987-05-11 | 1989-09-05 | Merck & Co., Inc. | 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils |
AU635642B2 (en) * | 1990-05-24 | 1993-03-25 | E.R. Squibb & Sons, Inc. | Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines |
USH1142H (en) * | 1990-11-05 | 1993-02-02 | Optically active cyclobutyl pyrimidine | |
ATE187173T1 (de) * | 1991-03-05 | 1999-12-15 | Ajinomoto Kk | Cyclopropanderivat |
-
1994
- 1994-10-19 KR KR1019940026704A patent/KR950011530A/ko not_active Application Discontinuation
- 1994-10-21 CA CA002134050A patent/CA2134050A1/en not_active Abandoned
- 1994-10-21 DE DE69429569T patent/DE69429569T2/de not_active Expired - Lifetime
- 1994-10-21 EP EP94307743A patent/EP0649840B1/de not_active Expired - Lifetime
- 1994-10-21 TW TW083109777A patent/TW271438B/zh active
- 1994-10-21 CN CN94117485A patent/CN1106392A/zh active Pending
- 1994-10-21 US US08/327,851 patent/US5496824A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR950011530A (ko) | 1995-05-15 |
US5496824A (en) | 1996-03-05 |
TW271438B (de) | 1996-03-01 |
EP0649840A1 (de) | 1995-04-26 |
EP0649840B1 (de) | 2002-01-02 |
CN1106392A (zh) | 1995-08-09 |
CA2134050A1 (en) | 1995-04-22 |
DE69429569T2 (de) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE251161T1 (de) | Triazolo(4,5-d)pyrimidin-derivate als antithrombotische mittel | |
DE69833223D1 (de) | 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin-abhängiger kinasen | |
DE69427270D1 (de) | Pyrimidin Derivate, Verfahren zu deren Herstellung und ihre Verwendung als herbizides Mittel | |
DE69838829D1 (de) | N-Phenyl-alkylsulfonamid-Derivate, deren Herstellung und deren Verwendung als alpha1A/1L-Adrenoceptor Agonisten | |
ATE224910T1 (de) | Derivate von dolestatin, deren herstellung und verwendung | |
ATE243682T1 (de) | Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide | |
ATE161253T1 (de) | Derivate und analoge der 2-deoxy-2,3-didehydro-n- acetyl-neuraminsäure und ihre verwendung als antivirale agentien | |
DE69816651D1 (de) | 2,3-diaryl-pyrazolo[1,5-b]pyridazin derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren | |
DE122008000020I1 (de) | Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel | |
ATE182880T1 (de) | Alkylthio-oximäther-derivate und deren verwendung als fungizide | |
DE69817611D1 (de) | 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate | |
DE69929820D1 (de) | Azyklische und zyklische guanidin- und acetamidin-derivate, deren herstellung und deren verwendung als pestizide, insbesondere als parasitizide | |
DE69410141T2 (de) | 1-(substituiertes Phenyl)-Tetrazolinon Derivate, deren Herstellung und deren Verwendung als Herbizide | |
ATE244720T1 (de) | 3-substituierte 3,4-dihydro-thieno 2,3- d)pyrimidin-derivate, ihre herstellung und verwendung | |
TR199801367A3 (tr) | 5H- tiazol (3,2-a) pirimidin türevleri | |
DE69928140D1 (de) | Antipicornavirale Verbindungen, deren Herstellung und Verwendung | |
DE19983612T1 (de) | Derivate von Isosorbidmononitrat und deren Verwendung als Gefäßerweiterungsmittel mit verringerter Toleranz | |
BR9711724A (pt) | Derivado de 3,4,5,6,7,8-hexaidro-pirido (4',3':4,5)tieno-(2,3-d) pirimidina 3-substitu¡da e uso do mesmo | |
DE59608723D1 (de) | Polycyclische Iminooxadiazindione, deren Herstellung und Verwendung | |
DE69706690T2 (de) | Acryloyl-substituierte distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel | |
DE69204909T2 (de) | Amino-Urazilderivate, deren Herstellung und Verwendung. | |
ATE203011T1 (de) | Distamycin derivate, verfahren zu ihrer herstellung sowie ihre verwendung als antitumor und antiviral wirkstoffe | |
ATE212346T1 (de) | 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung | |
DE59712148D1 (de) | 1,3-dimethyl-5-fluor-pyrazol-4-carboxamide derivative, deren herstellung und deren verwendung als mikrobizide | |
DE68918636D1 (de) | 1,2,4,5-Benzoylenbis(naphtho[1,8-de]pyrimidin)-Verbindungen und deren Verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |